Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–19 of 19 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07500298
- Conditions
- Bevacizimab, Colonic Diseases, Colorectal Neoplasms, +15 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT07072234
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Carcinoma, +6 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT06660420
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT07579208
- Conditions
- Astrocytoma, Chimera Antigen Receptor (CAR), EGFRvIII, +14 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Completed
A Study to Examine the Effect of Tesofensine and Metoprolol on the 24-hour Mean Heart Rate
NCT03488719
- Conditions
- Phase 1
- Locations
-
- Parexel International GmbH; Early Phase Clinical Unit Berlin Berlin, Germany
NCT05068947
- Conditions
- Phase 1
- Locations
-
- Clinical Pharmacology of Miami Hialeah, Florida, United States
NCT04327089
- Conditions
- Phase 1
- Locations
-
- Eurofins Optimed Gières, France
Completed
Comparison of the Relative Oral Bioavailability of GKT137831 Formulated in Capsules or in Tablets
NCT03740217
- Conditions
- Phase 1
- Locations
-
- Eurofins Optimed Gières, France
NCT03983876
- Conditions
- Phase 1
- Locations
-
- Christchurch Clinical Studies Trust Limited Christchurch, Chistchurch, New Zealand
- Auckland Clinical Studies Auckland, New Zealand
NCT04014257
- Conditions
- Phase 1, Solid Tumor, Adult
- Locations
-
- National Cancer Center Goyang-si, Gyeonggi-do, South Korea
- CHA Bundang Medical Center Seongnam-si, Gyeonggi-do, South Korea
- Seoul National University Hospital Seoul, South Korea
- Severance Hospital Seoul, South Korea
NCT03647670
- Conditions
- Phase 1
- Locations
-
- Pfizer Clinical Research Unit Brussels, Belgium
NCT03883620
- Conditions
- Arbovirus Infections, Dengue, Flaviviridae Infections, +8 more
- Locations
-
- CMAX Clinical Research Pty Ltd Adelaide, South Australia, Australia
NCT01091532
- Conditions
- Multiple Dose, Pharmacokinetic, Phase 1, +2 more
- Locations
-
- Pfizer Investigational Site Brussels, Belgium
NCT03273192
- Conditions
- Bioequivalence, Phase 1
- Locations
-
- Orchidpharmed PK/PD site Tehran, Iran
NCT03273088
- Conditions
- Bioequivalence, Phase 1
- Locations
-
- Orchidpharmed PK/PD site Tehrān, Tehran Province, Iran
Completed
EC905 Pharmacokinetic Profile Study
NCT02634489
- Conditions
- Benign Prostatic Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +20 more
- Locations
-
- Site NL1 Zuidlaren, Drenthe, Netherlands
- Conditions
- Bioavailability, Healthy Subjects, Phase 1
- Locations
-
- Parexel Berlin, Germany
NCT01415102
- Conditions
- Pharmacokinetics, Phase 1, Safety, +2 more
- Locations
-
- Pfizer Investigational Site Brussels, Belgium
Active, Not Recruiting
A Phase 1, Open-Label, Parallel-Group, Single-Dose Study To Compare The Pharmakokinetics Of TNX-102 SL (Cyclobenzaprine Hydrochloride Sublingual Tablet) In Non-Elderly Versus Elderly Participants
NCT07413367
- Conditions
- Open Label, Pharmakokinetic, Phase 1
- Locations
-
- Syneos Health Clinique, Inc. Québec, Quebec, Canada